NasdaqGM - Nasdaq Real Time Price USD

Climb Bio Inc (CLYM)

1.2400
-0.0300
(-2.36%)
At close: May 20 at 4:00:01 PM EDT
1.3000
+0.06
+(4.84%)
After hours: May 20 at 6:54:53 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
50,374
30,361
40,275
45,135
35,672
Operating Income
-50,374
-30,361
-40,275
-45,135
-35,672
Net Non Operating Interest Income Expense
9,078
8,132
4,620
1,375
--
Other Income Expense
-51,685
-51,668
536
-1,484
-11,808
Pretax Income
-92,981
-73,897
-35,119
-45,244
-47,480
Net Income Common Stockholders
-92,981
-73,897
-35,119
-45,244
-52,028
Diluted NI Available to Com Stockholders
-92,981
-73,897
-35,119
-45,244
-52,028
Basic EPS
-1.78
--
-1.30
-1.72
-4.24
Diluted EPS
-1.78
--
-1.30
-1.72
-4.24
Basic Average Shares
58,119.2820
--
26,987.1220
26,311.5540
12,260.5510
Diluted Average Shares
58,119.2820
--
26,987.1220
26,311.5540
12,260.5510
Total Operating Income as Reported
-102,033
-82,020
-40,275
-45,135
-35,672
Total Expenses
50,374
30,361
40,275
45,135
35,672
Net Income from Continuing & Discontinued Operation
-92,981
-73,897
-35,119
-45,244
-47,480
Normalized Income
-41,296
-22,229
-35,655
-43,760
-47,310
Interest Income
9,078
8,132
4,620
1,375
--
Net Interest Income
9,078
8,132
4,620
1,375
--
EBIT
-50,374
-30,361
-40,275
-45,135
-35,672
EBITDA
-50,374
-30,361
-40,275
-45,135
-35,672
Net Income from Continuing Operation Net Minority Interest
-92,981
-73,897
-35,119
-45,244
-47,480
Total Unusual Items Excluding Goodwill
-51,685
-51,668
536
-1,484
-170
Total Unusual Items
-51,685
-51,668
536
-1,484
-170
Normalized EBITDA
1,311
21,307
-40,811
-43,651
-35,502
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WHWK Whitehawk Therapeutics, Inc.
1.9900
+13.07%
 
ARTV Artiva Biotherapeutics, Inc.
2.1600
+6.93%
 
IKNA Ikena Oncology, Inc.
1.1300
+1.80%
 
BNTC Benitec Biopharma Inc.
13.93
-0.36%
 
PMN ProMIS Neurosciences, Inc.
0.5250
+1.74%
 
GNTA Genenta Science S.p.A.
4.4500
+0.23%
 
RAPP Rapport Therapeutics, Inc.
10.22
+0.29%
 
LYEL Lyell Immunopharma, Inc.
0.4218
+2.11%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.3100
-1.50%
 
SRZN Surrozen, Inc.
8.47
+5.48%